D.Caroline Blanchard, Guy Griebel, and Robert J. Blanchard

Gender bias in the preclinical psychopharmacology of anxiety: male models for (predominantly) female disorders
J Psychopharmacol 1995 9: 79-82. [PDF] [References]  

Aviv M. Weinstein and David J. Nutt

A cognitive dysfunction in anxiety and its amelioration by effective treatment with SSRIs
J Psychopharmacol 1995 9: 83-89. [Abstract] [PDF] [References]  

A. Patat, M.C. Perault, B. Vandel, Ph. Danjou, S. Brohier, I. Zieleniuk, and P. Rosenzweig

Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers
J Psychopharmacol 1995 9: 91-101. [Abstract] [PDF] [References]  

B.R.P. Birch and Ronald A. Miller

An assessment of resedation following flumazenil-induced antagonism of intravenous midazolam: comparison of psychomotor and amnesic recovery with a non-sedated reference group
J Psychopharmacol 1995 9: 103-111. [Abstract] [PDF] [References]  

M. Gorissen, P. Eling, G. van Luijtelaar, and A. Coenen

Effects of diazepam on encoding processes
J Psychopharmacol 1995 9: 113-121. [Abstract] [PDF] [References]  

M. Fried, M. Garrioch, B. Tiplady, and J.A.W. Wildsmith

The effects of inhaled nitrous oxide on some measures of attention
J Psychopharmacol 1995 9: 123-126. [Abstract] [PDF] [References]  

Luiz Dratcu, James W. Keating, Roy Sherwood, and Malcolm Lader

A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety
J Psychopharmacol 1995 9: 127-135. [Abstract] [PDF] [References]  

Jayne E. Bailey, John Potokar, Nick Coupland, and David J. Nutt

The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man
J Psychopharmacol 1995 9: 137-141. [Abstract] [PDF] [References]  

D.J. King, P. Best, G. Lynch, M.F. Mannion, R.C. Montgomery, B. Tiplady, and W. Yisak

The effects of remoxipride and chlorpromazine on eye movements and psychomotor performance in healthy volunteers
J Psychopharmacol 1995 9: 143-149. [Abstract] [PDF] [References]  

Hilary J. Scurlock, Ashok N. Singh, and Jose Catalan

Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection
J Psychopharmacol 1995 9: 151-154. [Abstract] [PDF] [References]  

Nicholas A. Moore

Is the 'A' in atypical really due to 2-adrenoceptor antagonism? A comment on: Putting the 'A' in atypical: does 2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?
J Psychopharmacol 1995 9: 155. [PDF] [References]  

P. Birkett

Winter Workshop on Schizophrenia, Les Diablerets, Switzerland, January 1994
J Psychopharmacol 1995 9: 157-160. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.